Evaluation of Cardiovascular Risk Among the Participants of the ESC Congress 2026

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2026 from 28-31 August 2026 in Munich, Germany. The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.
Epistemonikos ID: 4b0de6e863113bcb6a87f3692a0a543a33b562ec
First added on: Aug 21, 2026